A comprehensive view of Mount Sinai Health System. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Icahn School of Medicine researchers discover psychedelic drugs' therapeutic effects on depression, anxiety originate from underappreciated brain receptor, 5-HT1A; research highlights potential for designing non-hallucinogenic mental health treatments
Published: May 08, 2024 by Newswise - MedNews
Study shows that withdrawing aspirin and keeping high-risk heart patients on ticagrelor a month after a percutaneous coronary intervention improves outcomes and reduces bleeding by over half; the findings may change worldwide standard of care guidelines
Published: April 23, 2024 by Insurance Daily News
Mount Sinai researchers identify how a family of proteins activate immune cells related to inflammatory bowel disease; discovery may potentially lead to new treatments for conditions such as ulcerative colitis and Crohn's disease
Published: April 22, 2024 by Newswise - SciNews
Mount Sinai study finds stopping aspirin one month after coronary stenting procedures significantly reduces bleeding complications in heart attack patients
Published: April 08, 2024 by Contify Life Science News
Mount Sinai study finds inter-atrial shunts may benefit heart failure patients with reduced left ventricular ejection fraction, but harm those with preserved LVEF; further studies needed to confirm these findings
Published: April 08, 2024 by Contify Life Science News

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count